Scott Irwin is the Director of the Patient and Family Support Program and Professor of Psychiatry & Behavioral Neurosciences at Cedars-Sinai. He strives to improve outcomes for those with cancer or other progressive, potentially life-limiting illnesses, and their families, through leading-edge clinical services, ongoing research, and program development, improvement and implementation. Dr Irwin has served as the principal investigator in numerous trials exploring the effects of ketamine on mental health issues in patients with cancer.
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)